Clinical Trails to Evaluate H5N1 Influenza Variant Vaccines

$7,985,002N01FY2024AINIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Theresa Engelcontact

View original record on NIH RePORTER →